Intravitreal (IVT) Injectables Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market For

1. Intravitreal (IVT) Injectables Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029 Global Intravitreal Injectables Market Introduction: The global intravitreal (IVT) injectables market is poised to value over USD 5 billion by 2029 end. Intravitreal (IVT) injectables are immensely prevalent among eye specialists. Anti– vascular endothelial growth factor (anti-VEGF) drugs are primarily used for treating macular degeneration, retinal vein occlusion, diabetic retinopathy and others. Rising prevalence of these diseases has expanded the anti-VEGF market assisting the growth of global IVT market. Global Intravitreal Injectables Market Overview: Based on drug class, the market is fragmented into anti-VEGF, antibiotics, corticosteroids, antifungals and antivirals. Corticosteroids are primarily used for treating knee osteoarthritis, for reducing disease-induced inflammation, asthma, allergies, etc. However this is acstrong medicine and can cause weight gain, fragile bones, glaucoma, thinning of the skin and many more such side effects which hamper the market growth of this segment. Based on the type of indication, the market is bifurcated into diabetic retinopathy, macular degeneration, Endophthalmitis and retinal vein occlusions. Patients suffering from diabetes mellitus are more prone to get diabetic retinopathy and the diabetes mellitus patient pool is mainly found in the Asia Pacific region, India and China in particular. Therefore, this market segment has huge potential for its expansion in not only the Asia Pacific region but in the entire world. Distribution-wise, the market is categorised as hospital pharmacies, retail pharmacies, drug stores and mail order pharmacies. Global Intravitreal Injectables Market Regional Insight: The global IVT injectables market is regionally bifurcated into North America, Europe, Asia Pacific, Middle East & Africa and Latin America. North American region have shown high market growth owing to the high prevalence of blindness and low vision in the region and frequent prescription of anti-VEGF IVT injectables has propelled the market growth. Request a Sample Report@ https://www.futurewiseresearch.com/request- sample.aspx?id=259&page=requestsample Global Intravitreal Injectables Market Segmentation: 1. By Region • North America

2. • Europe • Asia Pacific • Middle East & Africa • Latin America 2. By Drug Class • Anti-VEGF • Antibiotics • Corticosteroids • Antifungals • Antivirals 3. By Indication • Diabetic Retinopathy • Macular Degeneration • Endophthalmitis • Retinal Vein Occlusions 4. By Distribution • Hospital Pharmacies • Retail Pharmacies • Drug Stores • Mail order Pharmacies Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request- sample.aspx?id=259&page=askfordiscount Competitive Landscape: • Bausch & Lomb • Novartis AG • Allergan • F. Hoffmann-La Roche Ltd. • Thrombogenics Inc. • Alimera Sciences FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global Intravitreal injectables market by region, by drug class, by indication, by distribution • To cater comprehensive information on factors impacting market growth (drivers,

3. restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Middle East & Africa and Latin America • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents Intravitreal (IVT) Injectables Market: Global Analysis and Forecast 2019- 2029 1. Market Introduction Market Taxonomy Market Definition 2. Executive Summary Market Overview Market Analysis 3. Market Dynamics Drivers Restraints Trends 4. Global Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019- 2029, by Drug Class 4.1. Introduction / Key Findings 4.2. Historical Market Size (US$ Mn) By Drug Class, 2019 - 2029 4.2.1. Anti-VEGF

4. 4.2.2. Corticosteroids 4.2.3. Antibiotics 4.2.4. Antivirals 4.2.5. Antifungals 4.3. Market Size (US$ Mn) Forecast By Drug Class, 2019-2029 5. Global Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019- 2029, by Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size (US$ Mn) By Indication, 2019 - 2029 5.2.1. Diabetic Retinopathy 5.2.2. Macular Degeneration 5.2.3. Endophthalmitis 5.2.4. Retinal Vein Occlusions 5.2.5. Others 5.3. Market Size (US$ Mn) Forecast By Indication, 2019-2029 6. Global Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019- 2029, by Distributional Channel

5. 6.1 Introduction / Key Findings 6.2. Historical Market Size (US$ Mn) By Distributional Channel, 2019 - 2029 6.2.1. Hospital Pharmacies 6.2.2. Retail Pharmacies 6.2.3. Drug Stores 6.2.4. Mail Order Pharmacies 6.2.5. Others 6.3. Market Size (US$ Mn) Forecast By Distributional Channel, 2019-2029 6.4. Market Attractiveness Analysis By Distributional Channel 7. Global Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019- 2029, by Region 7.1. Introduction 7.2. Historical Market Size (US$ Mn) By Region, 2019 - 2029 7.2.1. North America 7.2.2. Latin America 7.2.3. Europe 7.2.4. South Asia 7.2.5. East Asia

6. 7.2.6. Oceania 7.2.7. Middle East and Africa 7.2.8. Emerging Countries 7.3. Market Size (US$ Mn) Forecast By Region, 2019-2029 8. North America Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019-2029 Introduction Historical Market Size (US$ Mn) and By Country, 2019 – 2029 U.S. Canada Market Size (US$ Mn) Forecast By Country, 2019-2029 9. Latin America Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019-2029 Introduction Historical Market Size (US$ Mn) and Analysis By Country, 2019 - 2029 Brazil Mexico Rest of Latin America Market Size (US$ Mn) Forecast By Country, 2019-2029 10. Europe Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019-2029 Introduction

7. Historical Market Size (US$ Mn) and Analysis By Country, 2019 - 2029 Germany Italy France U.K. Spain BENELUX Russia Rest of Europe 11. South Asia Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019-2029 Introduction Historical Market Size (US$ Mn) and Analysis By Country, 2019 - 2029 India Thailand Indonesia Malaysia Rest of South Asia 12. East Asia Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019-2029 Introduction Historical Market Size (US$ Mn) and Analysis By Country, 2019 - 2029 China Japan South Korea

8. 13. Oceania Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019-2029 Introduction Historical Market Size (US$ Mn) and Analysis By Country, 2019 - 2029 Australia New Zealand 14. Middle East and Africa Intravitreal (IVT) Injectables Market Analysis 2019-2029 and Forecast 2019-2029 Introduction Historical Market Size (US$ Mn) and Analysis By Country, 2019 - 2029 GCC Countries Turkey Northern Africa South Africa Rest of Middle East and Africa 15. China Intravitreal Injectables (IVT) Market Analysis 2019–2029 and Forecast 2019–2029 16. India Intravitreal Injectables (IVT) Market Analysis 2019–2029 and Forecast 2019–2029 17. Competition Analysis F. Hoffmann-La Roche Ltd Regeneron Pharmaceuticals, Inc. Bausch & Lomb

9. Novartis AG Allergan Alimera Sciences ThromboGenics, Inc. Bristol-Myers Squibb Company Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com